neuromyelitis optica - PMC

Result Filters

You searched 8+ million full text articles

Try this search in 34+ million citations and abstracts

PMC Full-Text Search Results

Items: 1 to 20 of 12177

<< First< Prev

Page of 609

Next >Last >>

Select item 74553141.

Interleukin-6 in neuromyelitis optica spectrum disorder pathophysiology

Kazuo Fujihara, Jeffrey L. Bennett, Jerome de Seze, Masayuki Haramura, Ingo Kleiter, Brian G. Weinshenker, Delene Kang, Tabasum Mughal, Takashi Yamamura

Neurol Neuroimmunol Neuroinflamm. 2020 Sep; 7(5): e841. Published online 2020 Aug 20. doi: 10.1212/NXI.0000000000000841

PMCID:: PMC7455314

Abstract Article PDF–344K

Select item 102672802.

Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: Diagnosis and differential diagnosis

Sven Jarius, Orhan Aktas, Ilya Ayzenberg, Judith Bellmann-Strobl, Achim Berthele, Katrin Giglhuber, Vivien Häußler, Joachim Havla, Kerstin Hellwig, Martin W. Hümmert, Ingo Kleiter, Luisa Klotz, Markus Krumbholz, Tania Kümpfel, Friedemann Paul, Marius Ringelstein, Klemens Ruprecht, Makbule Senel, Jan-Patrick Stellmann, Florian Then Bergh, Hayrettin Tumani, Brigitte Wildemann, Corinna Trebst, Neuromyelitis Optica Study Group (NEMOS)

J Neurol. 2023; 270(7): 3341–3368. Published online 2023 Apr 6. doi: 10.1007/s00415-023-11634-0

PMCID:: PMC10267280

Abstract Article PDF–1.1M

Select item 83954033.

Treatment of Neuromyelitis Optica Spectrum Disorders

Koon-Ho Chan, Chi-Yan Lee

Int J Mol Sci. 2021 Aug; 22(16): 8638. Published online 2021 Aug 11. doi: 10.3390/ijms22168638

PMCID:: PMC8395403

Abstract Article PDF–397K

Select item 93234544.

Neuromyelitis Optica Spectrum Disorder: From Basic Research to Clinical Perspectives

Tzu-Lun Huang, Jia-Kang Wang, Pei-Yao Chang, Yung-Ray Hsu, Cheng-Hung Lin, Kung-Hung Lin, Rong-Kung Tsai

Int J Mol Sci. 2022 Jul; 23(14): 7908. Published online 2022 Jul 18. doi: 10.3390/ijms23147908

PMCID:: PMC9323454

Abstract Article PDF–950K

Select item 85617025.

Magnetic resonance imaging in neuromyelitis optica spectrum disorder

Laura Clarke, Simon Arnett, Kate Lilley, Jacky Liao, Sandeep Bhuta, Simon A Broadley

Clin Exp Immunol. 2021 Dec; 206(3): 251–265. Published online 2021 Jul 6. doi: 10.1111/cei.13630

PMCID:: PMC8561702

Abstract Article PDF–1.1M

Select item 62936096.

Comprehensive review of neuromyelitis optica and clinical characteristics of neuromyelitis optica patients in Puerto Rico

Sara Zarei, James Eggert, Laura Franqui-Dominguez, Yonatan Carl, Fernando Boria, Marina Stukova, Alessandro Avila, Cristina Rubi, Angel Chinea

Surg Neurol Int. 2018; 9: 242. Published online 2018 Dec 3. doi: 10.4103/sni.sni_224_18

PMCID:: PMC6293609

Abstract Article PDF–547K

Select item 107700207.

Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management

Tania Kümpfel, Katrin Giglhuber, Orhan Aktas, Ilya Ayzenberg, Judith Bellmann-Strobl, Vivien Häußler, Joachim Havla, Kerstin Hellwig, Martin W. Hümmert, Sven Jarius, Ingo Kleiter, Luisa Klotz, Markus Krumbholz, Friedemann Paul, Marius Ringelstein, Klemens Ruprecht, Makbule Senel, Jan-Patrick Stellmann, Florian Then Bergh, Corinna Trebst, Hayrettin Tumani, Clemens Warnke, Brigitte Wildemann, Achim Berthele, The Neuromyelitis Optica Study Group (NEMOS)

J Neurol. 2024; 271(1): 141–176. Published online 2023 Sep 7. doi: 10.1007/s00415-023-11910-z

Correction in:: J Neurol. 2024; 271(6): 3702–3707.

PMCID:: PMC10770020

Abstract Article PDF–1.3M

Select item 113113288.

Humanized-Aquaporin-4-Expressing Rat Created by Gene-Editing Technology and Its Use to Clarify the Pathology of Neuromyelitis Optica Spectrum Disorder

Chihiro Namatame, Yoichiro Abe, Yoshiki Miyasaka, Yoshiki Takai, Yuki Matsumoto, Toshiyuki Takahashi, Tomoji Mashimo, Tatsuro Misu, Kazuo Fujihara, Masato Yasui, Masashi Aoki

Int J Mol Sci. 2024 Aug; 25(15): 8169. Published online 2024 Jul 26. doi: 10.3390/ijms25158169

PMCID:: PMC11311328

Abstract Article PDF–3.9M

Select item 104473889.

Serum neurofilament light chain levels at attack predict post-attack disability worsening and are mitigated by inebilizumab: analysis of four potential biomarkers in neuromyelitis optica spectrum disorder

Orhan Aktas, Hans-Peter Hartung, Michael A Smith, William A Rees, Kazuo Fujihara, Friedemann Paul, Romain Marignier, Jeffrey L Bennett, Ho Jin Kim, Brian G Weinshenker, Sean J Pittock, Dean M Wingerchuk, Gary Cutter, Dewei She, Michele Gunsior, Daniel Cimbora, Eliezer Katz, Bruce A Cree, the N-MOmentum study investigators

J Neurol Neurosurg Psychiatry. 2023 Sep; 94(9): 757–768. Published online 2023 May 23. doi: 10.1136/jnnp-2022-330412

PMCID:: PMC10447388

Abstract Article PDF–2.9M

Select item 852403910.

A Comprehensive Review on the Role of Genetic Factors in Neuromyelitis Optica Spectrum Disorder

Soudeh Ghafouri-Fard, Tahereh Azimi, Mohammad Taheri

Front Immunol. 2021; 12: 737673. Published online 2021 Oct 5. doi: 10.3389/fimmu.2021.737673

PMCID:: PMC8524039

Abstract Article PDF–485K

Select item 844443611.

Neuromyelitis optica spectrum disorders: from pathophysiology to therapeutic strategies

Edgar Carnero Contentti, Jorge Correale

J Neuroinflammation. 2021; 18: 208. Published online 2021 Sep 16. doi: 10.1186/s12974-021-02249-1

PMCID:: PMC8444436

Abstract Article PDF–1.4M

Select item 1033869512.

Attack adjudication in neuromyelitis optica spectrum disorder: Substantiation of criteria by magnetic resonance imaging and biomarkers in N-MOmentum

Brian G Weinshenker, Dean M Wingerchuk, Ari J Green, Jeffrey L Bennett, Ho Jin Kim, Sean J Pittock, Kazuo Fujihara, Friedemann Paul, Gary Cutter, Romain Marignier, Orhan Aktas, Hans-Peter Hartung, Dewei She, Michael Smith, William Rees, Kristina Patterson, Daniel Cimbora, Eliezer Katz, Bruce AC Cree

Mult Scler. 2023 Jul; 29(8): 945–955. Published online 2023 Jun 6. doi: 10.1177/13524585231172145

PMCID:: PMC10338695

Abstract Article PDF–2.7M

Select item 966440213.

Association between B-cell depletion and attack risk in neuromyelitis optica spectrum disorder: An exploratory analysis from N-MOmentum, a double-blind, randomised, placebo-controlled, multicentre phase 2/3 trial

Jeffrey L. Bennett, Orhan Aktas, William A. Rees, Michael A. Smith, Michele Gunsior, Li Yan, Dewei She, Daniel Cimbora, Sean J. Pittock, Brian G. Weinshenker, Friedemann Paul, Romain Marignier, Dean Wingerchuk, Gary Cutter, Ari Green, Hans-Peter Hartung, Ho Jin Kim, Kazuo Fujihara, Michael Levy, Eliezer Katz, Bruce A.C. Cree, N-MOmentum study investigators

eBioMedicine. 2022 Dec; 86: 104321. Published online 2022 Nov 10. doi: 10.1016/j.ebiom.2022.104321

PMCID:: PMC9664402

Abstract Article PDF–3.4M

Select item 1023191314.

International Delphi Consensus on the Management of AQP4-IgG+ NMOSD: Recommendations for Eculizumab, Inebilizumab, and Satralizumab

Friedemann Paul, Romain Marignier, Jacqueline Palace, Georgina Arrambide, Nasrin Asgari, Jeffrey L. Bennett, Bruce Anthony Campbell Cree, Jérôme De Sèze, Kazuo Fujihara, Ho Jin Kim, Rebecca Hornby, Saif Huda, Najib Kissani, Ingo Kleiter, Satoshi Kuwabara, Marco Lana-Peixoto, Lisa Law, M. Isabel Leite, Lekha Pandit, Sean J. Pittock, Chao Quan, Sudarshini Ramanathan, Dalia Rotstein, Albert Saiz, Douglas Kazutoshi Sato, Adi Vaknin-Dembinsky

Neurol Neuroimmunol Neuroinflamm. 2023 Jul; 10(4): e200124. Published online 2023 May 31. doi: 10.1212/NXI.0000000000200124

PMCID:: PMC10231913

Abstract Article PDF–371K

Select item 1116852315.

Biomarkers for neuromyelitis optica: a visual analysis of emerging research trends

Xiangjun Li, Jiandong Zhang, Siqi Zhang, Shengling Shi, Yi’an Lu, Ying Leng, Chunyan Li

Neural Regen Res. 2024 Dec; 19(12): 2735–2749. Published online 2024 Apr 1. doi: 10.4103/NRR.NRR-D-24-00109

PMCID:: PMC11168523

Abstract Article PDF–3.5M

Select item 805497416.

Disability Outcomes in the N-MOmentum Trial of Inebilizumab in Neuromyelitis Optica Spectrum Disorder

Romain Marignier, Jeffrey L. Bennett, Ho Jin Kim, Brian G. Weinshenker, Sean J. Pittock, Dean Wingerchuk, Kazuko Fujihara, Friedemann Paul, Gary R. Cutter, Ari J. Green, Orhan Aktas, Hans-Peter Hartung, Fred D. Lublin, Ian M. Williams, Jorn Drappa, Dewei She, Daniel Cimbora, William Rees, Michael Smith, John N. Ratchford, Eliezer Katz, Bruce A.C. Cree

Neurol Neuroimmunol Neuroinflamm. 2021 May; 8(3): e978. Published online 2021 Mar 26. doi: 10.1212/NXI.0000000000000978

PMCID:: PMC8054974

Abstract Article PDF–720K

Select item 731177717.

Visualizing the Central Nervous System: Imaging Tools for Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders

Joseph Kuchling, Friedemann Paul

Front Neurol. 2020; 11: 450. Published online 2020 Jun 17. doi: 10.3389/fneur.2020.00450

PMCID:: PMC7311777

Abstract Article PDF–1.6M

Select item 479765418.

Differentiating neuromyelitis optica from other causes of longitudinally extensive transverse myelitis on spinal magnetic resonance imaging

Yeliz Pekcevik, Charles H Mitchell, Maureen A Mealy, Gunes Orman, In H Lee, Scott D Newsome, Carol B Thompson, Carlos A Pardo, Peter A Calabresi, Michael Levy, Izlem Izbudak

Mult Scler. Author manuscript; available in PMC 2016 Mar 18.

Published in final edited form as: Mult Scler. 2016 Mar; 22(3): 302–311. Published online 2015 Jul 24. doi: 10.1177/1352458515591069

PMCID:: PMC4797654

Abstract Article PDF–1.9M

Select item 648733419.

Outcome prediction models in AQP4-IgG positive neuromyelitis optica spectrum disorders

Jacqueline Palace, Dan-Yu Lin, Donglin Zeng, Masoud Majed, Liene Elsone, Shahd Hamid, Silvia Messina, Tatsuro Misu, Jessica Sagen, Daniel Whittam, Yoshiki Takai, Maria Isabel Leite, Brian Weinshenker, Philippe Cabre, Anu Jacob, Ichiro Nakashima, Kazuo Fujihara, Sean J Pittock

Brain. 2019 May; 142(5): 1310–1323. Published online 2019 Apr 1. doi: 10.1093/brain/awz054

PMCID:: PMC6487334

Abstract Article PDF–415K

Select item 733288220.

Epidemiology of Neuromyelitis Optica Spectrum Disorder and Its Prevalence and Incidence Worldwide

Jyh Yung Hor, Nasrin Asgari, Ichiro Nakashima, Simon A. Broadley, M. Isabel Leite, Najib Kissani, Anu Jacob, Romain Marignier, Brian G. Weinshenker, Friedemann Paul, Sean J. Pittock, Jacqueline Palace, Dean M. Wingerchuk, Jacinta M. Behne, Michael R. Yeaman, Kazuo Fujihara

Front Neurol. 2020; 11: 501. Published online 2020 Jun 26. doi: 10.3389/fneur.2020.00501

PMCID:: PMC7332882

Abstract Article PDF–928K

<< First< Prev

Page of 609

Next >Last >>

Supplemental Content

Filter your results:

Manage Filters

PMC Images search for neuromyelitis optica

Figure 1Flow chart of pregnancy history in participants with neuromyelitis optica

Participant numbers are reported for pregnancy history, timing of pregnancy related to neurologic symptom onset, and pregnancy outcome. NMOSD = neuromyelitis optica spectrum disorders.

High risk of postpartum relapses in neuromyelitis optica spectrum disorder

Neurology. 2017 Nov 28;89(22):2238-2244.
Figure 1Group Comparisons of GCIP Layer Thickness

Boxplots of GCIP layer thicknesses (μm) acquired by Heidelberg SD-OCT with values of individual eyes (jitter) for (A) HC (gray/left), NMOSD-NON (dark blue/middle), NMOSD-ON (dark red/right); for (B) number of ON episodes (NMOSD-NON dark blue/left, NMOSD-1-ON light red/left-middle, NMOSD-2-ON medium-red/right-middle, NMOSD-≥3-ON medium-dark red/right); and for (C) HC (gray/left), NMOSD-NON_non (light blue/middle), NMOSD-NON_con (blue/right). (D) Forest plots for results from different OCT devices for (D.a) NMOSD-NON vs NMOSD-ON, (D.b) NMOSD-NON vs NMOSD-1-ON, and (D.c) NMOSD-1-ON vs NMOSD-2-ON (eFigure 2 and eTable 2, links.lww.com/NXI/A556 and links.lww.com/NXI/A557). GCIP = ganglion cell and inner plexiform; HC = eyes of HCs; NMOSD-NON = eyes of patients with neuromyelitis optica without a history of ON; NMOSD-NON-_con = eyes of patients with neuromyelitis optica without a history of ON but a history of contralateral ON; NMOSD-NON_non: = eyes of patients with neuromyelitis optica without a history of ipsilateral or contralateral ON; NMOSD-ON = eyes of patients with neuromyelitis optica with a history of ON; NMOSD-1-ON = eyes of patients with neuromyelitis optica with a history of 1 ON episode; NMOSD-2-ON = eyes of patients with neuromyelitis optica with a history of 2 ON episodes; ON = optic neuritis.

Retinal Optical Coherence Tomography in Neuromyelitis Optica

Neurol Neuroimmunol Neuroinflamm. 2021 Nov;8(6):e1068.
Figure 3

(A, C, E) C3, C4 and CH50 values and (B, D, F) the frequencies of patients with high C3, C4 and CH50 values among EBLs, NEBLs and NEBLs*. EBLs; neuromyelitis optica with extensive brain lesions; NEBLs: neuromyelitis optica without extensive brain lesions; NEBLs*:AQP4-seropositive neuromyelitis optica without extensive brain lesions.

Clinical, radiographic characteristics and immunomodulating changes in neuromyelitis optica with extensive brain lesions

BMC Neurol. 2013;13:72-72.
Figure 2Group Comparisons of pRNFL Thickness

Boxplots of pRNFL thicknesses acquired by Heidelberg SD-OCT [μm] with values of individual eyes (jitter) for (A) HC (gray/left), NMOSD-NON (dark blue/middle), and NMOSD-ON (dark red/right); for (B) number of ON episodes (NMOSD-NON dark blue/left, NMOSD-1-ON light red/left-middle, NMOSD-2-ON medium-red/right-middle, and NMOSD-≥3-ON medium-dark red/right); and for (C) HC (gray/left), NMOSD-NON_non (light blue/middle), and NMOSD-NON_con (blue/right). (D) Forest plots for results from different OCT devices for (D.a) NMOSD-NON vs NMOSD-ON, (D.b) NMOSD-NON vs NMOSD-1-ON, and (D.c) NMOSD-1-ON vs NMOSD-2-ON (eFigure 3 and eTable 3, links.lww.com/NXI/A556 and links.lww.com/NXI/A557). HC = eyes of HCs; NMOSD-NON = eyes of patients with neuromyelitis optica without a history of optic neuritis; NMOSD-NON-_con = eyes of patients with neuromyelitis optica without a history of optic neuritis but a history of contralateral optic neuritis; NMOSD-NON_non: = eyes of patients with neuromyelitis optica without a history of ipsilateral or contralateral optic neuritis; NMOSD-ON = eyes of patients with neuromyelitis optica with a history of optic neuritis; NMOSD-1-ON = eyes of patients with neuromyelitis optica with a history of 1 optic neuritis episode; NMOSD-2-ON = eyes of patients with neuromyelitis optica with a history of 2 optic neuritis episodes; ON = optic neuritis; pRNFL = peripapillary retinal nerve fiber layer.

Retinal Optical Coherence Tomography in Neuromyelitis Optica

Neurol Neuroimmunol Neuroinflamm. 2021 Nov;8(6):e1068.